Delivery Order SPE2DB22D2206-SPE2DB23FHW24
Award Date 6/26/23
Potential Completion Date 6/27/23
Potential Value $14K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $10,000.07 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. Under this contract, Amerisourcebergen will provide approximately 2,000 units of the drug to support the Department of Defense's medical supply needs. As the prime contractor, Amerisourcebergen will leverage its extensive distribution network and pharmaceutical supply chain expertise. No subcontractors or set aside designations were specified....
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $13,655.88 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,184,849 units of the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. This order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp as the prime contractor. The IDC enables Amerisourcebergen to deliver a comprehensive range of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $4,059.09 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4563942820 DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC...
- This is a $1,709.46 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of DUPIXENT 300 MG/2 ML PEN 2ML. The contract has an ultimate completion date of May 29, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle...
- The Defense Logistics Agency awarded a $35,472.10 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. Under this single award, Amerisourcebergen will provide approximately 2,000 pens of the injectable drug to support DLA's medical supply needs. As the prime, Amerisourcebergen will perform the order itself out of its Conshohocken, Pennsylvania distribution facility. No subcontractors or set aside designations were specified. This award is...
- The Defense Logistics Agency awarded a $13,102 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. As the prime contractor, Amerisourcebergen will deliver the medication to its place of performance in Conshohocken, Pennsylvania by September 7, 2023 to support DLA procurement programs. No subcontractors or set aside designations were identified. DLA manages the global supply chain for the military to ensure troops have the resources and materials...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide DUPIXENT 300 MG/2 ML PEN 2ML pharmaceuticals. The award, valued at $5,921.36, has a completion date of February 28, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, which is not associated with any set-aside program. This delivery order is issued under a larger indefinite delivery contract (IDC)...
- This is a $35,757.50 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide DUPIXENT 300 MG/2 ML PEN 2ML. The contract has an ultimate completion date of June 10, 2025 and is not set aside. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for the Defense Health...
- This is a $33,212.71 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products. The order has an ultimate completion date of August 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical for providing a comprehensive range of medical commodities to support...
- The Defense Logistics Agency awarded a $15,656 delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. As the prime contractor, Amerisourcebergen will supply the biologic drug to the DLA under a firm fixed price contract running from September 25 to 26, 2023. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will perform the order from its facility in Conshohocken, Pennsylvania. No additional subcontractors or set aside designations were identified....